Back to Trades
Sell4
REPLIGEN CORP
RGEN
Total Value
$3.3M
Net $3.1M sold
Sales
$3.1M
7 transactions
Company Information
- Company Name
- REPLIGEN CORP
- Ticker Symbol
- RGEN
- CIK
- 0000730272
Insider Information
- Name
- Hunt Anthony
- Role
- Insider
- Location
- WALTHAM, MA
Filing Details
- Filing Date
- Nov 14, 2025
- Transaction Date
- Nov 13, 2025
- Accession Number
- 0001193125-25-283092
- Form Type
- 4
- Net Trading Amount
- -$3.1M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Nov 13, 2025 | Common Stock | 1,784 | $151.01 | Sale | $269.4K |
| Nov 13, 2025 | Common Stock | 2,100 | $152.17 | Sale | $319.6K |
| Nov 13, 2025 | Common Stock | 2,923 | $153.14 | Sale | $447.6K |
| Nov 13, 2025 | Common Stock | 2,500 | $154.32 | Sale | $385.8K |
| Nov 13, 2025 | Common Stock | 3,000 | $155.45 | Sale | $466.4K |
| Nov 13, 2025 | Common Stock | 5,737 | $156.22 | Sale | $896.2K |
| Nov 13, 2025 | Common Stock | 1,956 | $157.11 | Sale | $307.3K |
| Nov 13, 2025 | Common Stock | 2,952 | $33.87 | Exercise | $100.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Nov 13, 2025 | Derivative | 2,952 | $33.87 | Exercise | $100.0K |
Footnotes
- (F1)$151.01 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.53 to $151.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- (F2)$152.17 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.57 to $152.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- (F3)$153.14 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.64 to $153.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- (F4)$154.32 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.66 to $154.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- (F5)$155.45 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.78 to $155.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- (F6)$156.22 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.79 to $156.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- (F7)$157.11 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.90 to $157.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- (F8)14,760 of the shares underlying this option have vested. The remaining shares vest as follows: 2,952 shares on March 1, 2026, and 2,952 shares on March 1, 2027.